Espoo, Finland, 2014-10-09 08:45 CEST (GLOBE NEWSWIRE) --
Aspocomp Group Plc, Company Announcement, October 9, 2014 at 9:45 a.m.
Aspocomp is actively seeking new customer groups to round out its operations in the telecommunications segment. Expansion targets include the automotive, pharmaceutical, industrial electronics and security/aerospace sectors in particular. In the future, Aspocomp will pursue growth not only in its main markets in Scandinavia and Central Europe, but also in North America.
Under the new strategy, Aspocomp will offer more comprehensive service to its customers. Operating as a service business, the company provides technology solutions and competitive products. With its new strategy, the company can meet customers’ demand throughout the product life cycle and improve its own factory’s utilization and profitability better than before. To a growing extent, products will be manufactured utilizing carefully selected and cost-effective production lines in Asia. In Finland, the company is looking into combining production and development activities and focusing on the latest and most challenging technologies as well as the production of small and quick-turn series.
As part of Aspocomp’s strategic transformation the company has today issued a notice on statutory labor co-determination concerning all its personnel at the Teuva plant regarding the consolidation of production in Finland and the possible closing of the Teuva plant. The company expects that combining production and development in Finland will yield annual savings of approximately EUR 0.9 million. The cooperation negotiations concern a total of 36 employees.
The company will publish a stock exchange release concerning the decisions as soon as the cooperation negotiations are concluded. It is estimated that the cooperation negotiations will be concluded by the end of November. In the event the negotiations lead to the closing of the Teuva plant, it would generate a one-time cost of about EUR 1.5 million to be recognized in the last quarter of 2014.
The company’s full-year guidance remains unchanged. In 2014, net sales are expected to be between EUR 20 and 25 million and operating profit without one-time items between EUR -0.5 and EUR 1.5 million.
For further information, please contact Mikko Montonen, CEO, tel. +358 20 775 6860, mikko.montonen(at)aspocomp.com.
ASPOCOMP GROUP PLC
Mikko Montonen
CEO
Distribution:
Nasdaq OMX Helsinki
Major media
www.aspocomp.com
Aspocomp – PCB technology company
Aspocomp develops and sells PCB manufacturing services, focusing on the end-to-end fulfillment of customers’ PCB needs. Our seasoned professionals help customers to create the most optimal PCB designs, both in terms of performance and cost. Our trimmed production lines produce the most challenging designs with the shortest lead-times in the industry. Operating as a service business, we provide one-stop access to technology solutions and competitive products for all PCB technologies.
A printed circuit board (PCB) is the principal interconnection method in electronic devices. PCBs are used for electrical interconnection and as a component assembly platform in most electronic applications. Aspocomp’s PCBs are used in many applications, such as telecommunication networks and devices, automotive electronics, security and medical systems, chipset development and industrial automation.
ASPOCOMP RENEWS ITS STRATEGY AND SEEKS GROWTH AND
Top 10 Most Recent News Articles
Stephanie L. Beiermann Shines in HR Consulting Honors
Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...
Continue Reading
AvidXchange Acquisition Faces Fairness Investigation
Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...
Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious
Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...
Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD
Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...
Continue Reading
Giovanni Recalde Sues County After False Report
Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...
Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins
Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...
Continue Reading
OREF Opens $185,000 Research Grant Funding Cycle Today
A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...
Continue Reading
Armada Moves up as Key Player in US SI Exports
Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...
Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud
Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...
Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit
An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...
Continue ReadingTop 5 Most Recently Viewed Articles
T-Mobile US: A Decade of Impressive Stock Growth Revealed
T-Mobile US and Its Remarkable Growth Journey T-Mobile US (NASDAQ: TMUS) has shown exceptional growth over the last decade. With an annualized return rate of 20.05%, the company has outpaced the broader market by 8.22%. As of the latest information available, T-Mobile's market capitalization stands at an impressive $269.40 billion, highlighting its substantial position...
Continue Reading
Analysts Adjust TFI International's Forecasts After Q3 Report
TFI International Reports Weaker-Than-Expected Q3 Earnings After the market closed on a recent Monday, TFI International (NYSE: TFII) announced its quarterly earnings figures, which unfortunately fell below expectations. The company reported earnings of $1.60 per share, compared to analyst predictions of $1.78 per share. In addition, TFI International's quarterly revenue...
Continue Reading
C3.ai Investors Face Class Action Amidst Poor Financial Results
C3.ai Class Action Overview The Portnoy Law Firm is stepping forward to represent investors of C3.ai, Inc. as a class action develops. This legal move comes after concerning preliminary financial results announced by the company. Investors who purchased securities of C3 during the specified class period are encouraged to engage with the firm. Details of the Legal Class...
Continue Reading
21st.BIO Seeks EU Nod for Precision Fermentation Tech
Is Precision Fermentation Europe's Next Big Bet? Here we go again with another tech trying to revolutionize the food industry, and this time it's the Danish company 21st.BIO making strides in Europe. They've tossed their hat in the ring with an EU Novel Food application for BLG Essential+™, hoping to weave precision fermentation into the fabric of European food...
Continue Reading
Key Pfizer Executives Support Current Leadership Amid Challenges
Support for Pfizer's Leadership from Former Executives In a recent statement, former Pfizer executives, Ian Read and Frank D'Amelio, clarified their stance regarding the ongoing campaign by activist investor Starboard Value. They emphasized that they will not be engaging with Starboard, which has been advocating for changes within the pharmaceutical giant to enhance its...
Continue Reading